Article
Boston - Just as the trend in psoriasis treatment veers toward more systemic modalities with the biologic revolution, a new topical treatment with low toxicity may provide solutions for patients who have not responded to conventional therapy.
Polynucleotide Therapy Shows Promise in Scar and Burn Management
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Maximizing the 2-Fold Benefits of Your Charitable Donations
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference